Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

No abstract is available for this paper.

• Publication year

  1972

• Venue

  Immunology

• Publication date

  1972-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 4538884PMCID PMC1407968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective depletion of lymphoid tissue by cyclophosphamide.

  1972cited by this paper
• Studies on the induction of immunological tolerance by antigen in guinea-pigs already sensitized to dinitrochlorobenzene.

  1971cited by this paper
• Studies on the ability of the subcellular fractions of epidermis, painted in vivo with DNFB, to cause contact sensitization in the guinea pig.

  1970cited by this paper
• STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS

  1969cited by this paper
• Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.

  1967cited by this paper
• Separation of 7S gamma-1-globulin, 7S gamma-2-globulin and macroglobulin guinea pig antibodies.

  1966cited by this paper
• A study of the passive cellular transfer of local cutaneous hypersensitivity. I. Passive transfer of delayed hypersensitivity in inbred and outbred guinea-pigs.

  1965cited by this paper
• A HISTOLOGICAL AND AUTORADIOGRAPHIC STUDY OF LYMPH NODES DURING THE DEVELOPMENT OF CONTACT SENSITIVITY IN THE GUINEA-PIG.

  1965cited by this paper
• STUDIES ON THE MECHANISM OF ACTION OF METHOTREXATE AND CYCLOPHOSPHAMIDE ON CONTACT SENSITIVITY IN THE GUINEA PIG.

  1964cited by this paper

• Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target

  2025cites this paper
• Suppressive mechanisms of regulatory B cells in mice and humans

  2022cites this paper
• Novel Frontiers in Regulatory B cells

  2021cites this paper
• Cancer Immunotherapy Confers a Global Benefit

  2020cites this paper
• Effects of Cytotoxic Immunosuppressants on Tuberculin -Sensitive Lymphocytes in Guinea Pigs

  2017cites this paper
• Therapeutic Potential of Nigella sativa Oil Against Cyclophosphamide-Induced DNA Damage and Hepatotoxicity

  2017cites this paper
• Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts

  2013cites this paper
• Effect of treatment with cyclophosphamide in low doses upon the onset of delayed type hypersensitivity in mice chronically infected with Trypanosoma cruzi: involvement of heart interstitial dendritic cells

  2013cites this paper
• The Pharmacological and Immunological Basis for the Use of Immunosuppressive Drugs

  2012cites this paper
• A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

  2012cites this paper
• Cancer immunotherapy – revisited

  2011cites this paper
• Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes.

  2011cites this paper
• Toll-like receptors: tools, assays, and implications for in vitro pyrogen tests

  2009cites this paper
• UvA-DARE ( Digital Academic Repository ) Toll-like receptors : tools , assays , and implications for in vitro pyrogen tests

  2009cites this paper
• Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease.

  2009cites this paper
• Delayed hypersensitivity to tuberculin in rats: effects of antirheumatic drugs.

  2009cites this paper
• THE CELLULAR RESPONSE IN REGIONAL LYMPH NODES AND THYMUS TO REPEATED APPLICATION OF OXAZOLONE TO THE SKIN

  2009cites this paper
• Cell-Mediated Immunity in Clinical Diagnosis and Treatment 50 Diagnostic Measures Based on Cell-Mediated Immune Reactions 50 Augmentation of the Immune Response 56 6

  2009cites this paper
• UvA-DARE ( Digital Academic Repository ) Toll-like receptors : tools , assays , and implications for in vitro pyrogen tests

  2009cites this paper
• Other Forms of Immunosuppression

  2009cites this paper
• Immunological Spectra in Infectious Diseases

  2008cites this paper
• Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide.

  2008cites this paper
• Abnormal variation of the immune response as related to cancer

  2008cites this paper
• Strategies for exploiting the immune system to achieve prevention and improve therapy of cancer

  2007cites this paper
• Experimental Leishmania (L.) amazonensis Leishmaniasis: Characterization and Immunogenicity of Subcellular Fractions

  2007cites this paper
• Foxp 3 + CD 25 + Reduction of CD 4 in the NOD Mouse Is Associated with a Cyclophosphamide-Induced Type-1 Diabetes

  2006cites this paper
• Cyclophosphamide-Induced Type-1 Diabetes in the NOD Mouse Is Associated with a Reduction of CD4+CD25+Foxp3+ Regulatory T Cells1

  2006cites this paper
• Cancer chemotherapeutics as immunomodulators

  2005cites this paper
• Modulation of the immune system in the mouse. 2. Drug administration following antigen sensitization

  2005cites this paper
• Evaluation of various cytostatic drugs as local immunotherapeutic agents

  2004cites this paper
• Beneficial effects of enriched environment on adolescent rats from stressed pregnancies

  2004cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets

  2004cites this paper
• Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan

  2004cites this paper
• The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour

  2004cites this paper
• The effects of selective immunosuppression on resistance toMesocestoides corti in strains of mice showing high and low initial susceptibility

  2004cites this paper
• Regional lymph node x-radiation suppresses allograft rejection

  2004cites this paper
• T-T-cell interaction in delayed hypersensitivity (DH) response in mice induced by immunization with methylated human serum albumin (MHSA) in complete Freund's adjuvant (CFA), as revealed by cell transfer study and adult thymectomy

  2003cites this paper
• Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression.

  2003cites this paper
• Subtractive immunization: a tool for the generation of discriminatory antibodies to proteins of similar sequence.

  2002cites this paper
• Management of rheumatoid arthritis: the historical context.

  2001cites this paper
• Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: functional roles of interleukin-5-producing CD4(+) lymphocytes.

  2000cites this paper
• Historical Overview of Biologic Response Modifiers

  2000cites this paper
• Immunopathology of Chagas disease.

  1999cites this paper
• Draining lymph node cells of contact-sensitized mice induce suppression of contact sensitivity.

  1997cites this paper
• Cyclophosphamide‐induced blood and tissue eosinophilia in contact sensitivity: Mechanism of hapten‐induced eosinophil recruitment into the skin

  1997cites this paper
• The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model.

  1997cites this paper
• 6 – Immunoregulation: The Search for the Holy Grail

  1997cites this paper
• Mycophenolate Mofetil, Azathioprine and Cyclophosphamide Enhanced Efficacy Combined with Cyclosporine in Rat Cardiac Transplantation

  1997cites this paper
• Cyclophosphamide and interleukin-12 synergistically upregulate the acquisition of allergic contact dermatitis in the mouse.

  1996cites this paper
• Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells

  1996cites this paper
• The root of the solution.

  1995cites this paper
• Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.

  1994cites this paper
• Interleukin-5 is necessary for eosinophilia induced by cyclophosphamide in immunized mice.

  1993cites this paper
• Enhancement of interleukin-4 production by pertussis toxin

  1993cites this paper
• Subtractive immunization techniques for the production of monoclonal antibodies to rare antigens.

  1992cites this paper
• Generation of monoclonal antibodies specific for developmentally regulated antigens of the chicken retina.

  1991cites this paper
• Successful induction of allergic contact dermatitis to mercury and chromium in mice.

  1991cites this paper
• Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.

  1991cites this paper
• Changes in the adhesive phenotype of regional lymphocytes in rats with adjuvant arthritis: alteration by cyclophosphamide.

  1991cites this paper
• Pathogenesis of Chagas' disease.

  1991cites this paper
• Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine.

  1991cites this paper
• Enhancing effects of locally administered cytostatic drugs on T effector cell functions in mice.

  1990cites this paper
• Immunoregulation and Active Specific Immunization in Cancer Treatment

  1990cites this paper
• Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation.

  1990cites this paper
• Relationship between the effect of cyclophosphamide on adjuvant arthritis severity, skin allograft rejection and spleen cell cytotoxic activity in rats.

  1990cites this paper
• Modification of swine serum-induced bile duct lesion in BALB/c mice by cyclophosphamide.

  1990cites this paper
• Dose-Effects and Dose-Responses in Immunotoxicology: Problems and Conceptual Considerations

  1990cites this paper
• Immune alterations in rats following subacute exposure to tributyltin oxide.

  1990cites this paper
• Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis.

  1990cites this paper
• Intravenous cyclophosphamide therapy of severe SLE.

  1989cites this paper
• Effects of anticancer drugs on the immune system in humans.

  1989cites this paper
• Studies on the mechanism of action of Semecarpus anacardium in rheumatoid arthritis.

  1989cites this paper
• Strong delayed-type hypersensitivity induced against house dust mite antigens in the mice.

  1989cites this paper
• Protective and immunostimulating activity of a low dose of cyclophosphamide in the experimental infection of mice with foot-and-mouth disease virus

  1989cites this paper
• Tumor-infiltrating lymphocytes cultured in recombinant interleukin-2: enhancement of growth, cytotoxicity, and phenotypic expression of cytotoxic T-cell antigens by cyclophosphamide given intravenously prior to tumor harvest.

  1989cites this paper
• Abnormal Variation of the Immune System as Related to Cancer

  1989cites this paper
• Development of a leukocytopenic baby guinea pig model with azathioprine and cyclophosphamide.

  1989cites this paper
• Increased production of Kurloff cells and accompanying lymphocyte subset changes in immunized guinea-pigs treated with cyclophosphamide and cyclosporin A.

  1988cites this paper
• Attempts to induce tolerance with cyclophosphamide after renal transplantation in swine.

  1988cites this paper
• The Pharmacology of Lymphocytes

  1988cites this paper
• Monoclonal antibodies produced against antigenic determinants present in complex mixtures of proteins.

  1988cites this paper
• Murine model of intracerebral toxoplasmosis.

  1987cites this paper
• Enhancement of the delayed-type hypersensitivity reaction by oxazaphosphorines.

  1987cites this paper
• Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.

  1987cites this paper
• Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies.

  1987cites this paper
• Changes in lymphocyte subsets after treatment with cyclophosphamide and during the development of contact sensitivity in the guinea pig.

  1987cites this paper
• The mucosal regulation of the systemic immune response to cholera toxin.

  1987cites this paper
• Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide.

  1987cites this paper
• Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice

  1987cites this paper
• Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.

  1987cites this paper
• Effects of immunomanipulations on resistance induced by irradiated Schistosoma mansoni cercarial sensitization of C57BL/6 and CBA/J mice.

  1986cites this paper
• Local Administration of Various Cytostatic Drugs after Subcutaneous Immunization Enhances Delayed‐Type Hypersensitivity Reaction to Sheep Red Blood Cells in Mice

  1986cites this paper
• Effect of cyclophosphamide on T-lymphocyte marker expression in T-cell areas of some lymphoid organs of the rat.

  1986cites this paper
• Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.

  1986cites this paper
• Cutaneous sensitivity induced by immunization with irradiated Schistosoma mansoni cercariae. I. Induction, elicitation, and adoptive transfer analysis of cell-mediated cutaneous sensitivity.

  1986cites this paper
• Cutaneous sensitivity induced by immunization with irradiated Schistosoma mansoni cercariae. II. Autoimmunoregulation of cell-mediated cutaneous sensitivity and its reversal.

  1986cites this paper
• Cyclophosphamide treatment in polyarteritis nodosa

  1986cites this paper
• Genetic control of delayed-type hypersensitivity in mice to Salmonella antigen.

  1986cites this paper
• The immunoaugmenting effects of cancer chemotherapeutic agents.

  1986cites this paper